Delayed nephrectomy has comparable long-term overall survival to immediate nephrectomy for cT1a renal cell carcinoma: A retrospective cohort study.
BAUS ePoster online library. Tan W. Jun 25, 2019; 259574; P8-1
Dr. Wei Shen Tan
Dr. Wei Shen Tan
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)

Current recommendations suggest that nephrectomy or thermal ablation is a recommended treatment option for small renal mass (≤4 cm). This study examined long-term overall survival (OS) of patients managed with delayed and immediate nephrectomy of cT1a renal cancer.


We utilized the National Cancer Database (2005-2010) to identify 14,677 patients (immediate nephrectomy: 14,050 vs late nephrectomy: 627) aged <70 years with Charlson Comorbidity Index (CCI) 0 and cT1aN0M0 renal cell carcinoma (RCC). Immediate nephrectomy and late nephrectomy were defined as nephrectomy performed <30 days and >180 days from diagnosis respectively. Inverse probability of treatment weighting (IPTW)–adjusted Kaplan-Meier curves and Cox proportional hazards regression analyses were used to compare OS of patients in the two treatment arms. Influence of patient age and CCI on treatment effect was tested by interactions. Additional sensitivity analysis was performed to explore the outcome of delaying nephrectomy for >12 months. Post-hoc power calculations were performed.

Median age of patients were 55 years with a median follow-up of 82.5 months. IPTW-adjusted Kaplan-Meier curves suggest not significant difference between treatment arms (Hazard ratio, 0.96; 95% confidence interval, 0.73 to 1.26; p=.77). This outcome was consistent between all patients regardless of age (p=.48). Sensitivity analysis report no difference in overall survival even if nephrectomy was delayed by >12 months (p=.60).

We report that delayed and immediate nephrectomy for cT1a RCC confers comparable long-term overall survival. The findings of this study support the use of surveillance as a first-line management strategy for small renal masses.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings